Melanoma and Neoplasms of Skin
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: closed (30 September 2013) | Viewed by 76795
Special Issue Editor
Interests: melanoma; metastasis; microenvironment; tumor lymphangiogenesis; melanoma models; tumor biology; rare skin tumors; dermatopathology
Special Issue Information
Dear Colleagues,
All malignant skin neoplasms together account for more than 50% of all human cancers. Cutaneous squamous cell carcinoma and basal cell carcinoma (non-melanoma skin cancers), are the most numerous of skin tumors, with incidence rates of up to 90 per 100.000. Although the mortality of these tumors is clearly much lower than of melanoma, patients often have to suffer from multiple, sometimes even mutilating, therapeutic procedures.
In 2008, more than 20.000 patients died of cutaneous melanoma in Europe. Nowadays, incidence rates increased to 20 patients per 100,000. For a long period, the only option for successful therapy consisted of early surgery. Recently, new therapeutic options have become to be available, starting to give hope for patients.
Merkel cell carcinoma, cutaneous lymphoma or cutaneous sarcoma are rare but highly malignant skin neoplasms. Patients affected by these tumors often face diagnostic problems and the lack of available therapy.
Because of their mortality, the number of affected patients, increasing incidence rates, as well as therapeutic considerations, skin neoplasms represent an important socioeconomic health problem.
Dr. Robert Loewe
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- non-melanoma skin cancer
- Merkel cell carcinoma
- cutaneous lymphoma
- skin neoplasm
- non-melanoma skin cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.